A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer
Clinical trial NCT00437268 · COMPLETED
Trial details
- NCT number
- NCT00437268
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2009-05-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.